Arch Capital Group Ltd. (NASDAQ:ACGL – Get Free Report) CEO Marc Grandisson sold 103,028 shares of the stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $85.01, for a total transaction of $8,758,410.28. Following the sale, the chief executive officer now owns 1,937,157 shares in the company, valued at approximately $164,677,716.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Arch Capital Group Stock Down 1.5 %
ACGL opened at $84.12 on Thursday. The company has a current ratio of 0.57, a quick ratio of 0.59 and a debt-to-equity ratio of 0.22. Arch Capital Group Ltd. has a 1-year low of $55.62 and a 1-year high of $90.65. The company has a market capitalization of $31.37 billion, a PE ratio of 10.84, a PEG ratio of 1.11 and a beta of 0.68. The firm’s 50 day simple moving average is $81.60 and its two-hundred day simple moving average is $77.17.
Arch Capital Group (NASDAQ:ACGL – Get Free Report) last released its quarterly earnings results on Tuesday, October 31st. The insurance provider reported $2.31 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.77. The business had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.46 billion. Arch Capital Group had a net margin of 23.46% and a return on equity of 23.06%. During the same period last year, the firm earned $0.28 earnings per share. As a group, equities analysts forecast that Arch Capital Group Ltd. will post 7.67 EPS for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Arch Capital Group
Institutional Trading of Arch Capital Group
Several institutional investors and hedge funds have recently modified their holdings of ACGL. Cambridge Investment Research Advisors Inc. raised its position in shares of Arch Capital Group by 3.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 23,800 shares of the insurance provider’s stock valued at $1,152,000 after purchasing an additional 799 shares during the period. HighTower Advisors LLC raised its position in shares of Arch Capital Group by 27.1% during the 1st quarter. HighTower Advisors LLC now owns 34,331 shares of the insurance provider’s stock valued at $1,662,000 after purchasing an additional 7,316 shares during the period. Cetera Advisor Networks LLC raised its position in shares of Arch Capital Group by 33.0% during the 1st quarter. Cetera Advisor Networks LLC now owns 6,567 shares of the insurance provider’s stock valued at $318,000 after purchasing an additional 1,631 shares during the period. Private Advisor Group LLC raised its position in shares of Arch Capital Group by 12.3% during the 1st quarter. Private Advisor Group LLC now owns 14,025 shares of the insurance provider’s stock valued at $679,000 after purchasing an additional 1,537 shares during the period. Finally, Acadian Asset Management LLC bought a new stake in Arch Capital Group in the 1st quarter valued at $76,000. 87.21% of the stock is currently owned by institutional investors.
About Arch Capital Group
Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service contract reimbursement products; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile and inland marine products.
Featured Stories
- Five stocks we like better than Arch Capital Group
- What Makes a Stock a Good Dividend Stock?
- Investing in large cap stocks: Diving into big caps
- What is the Hang Seng index?
- Why you can make Vertex Pharmaceuticals a buy on any pullback
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Occidental Petroleum: Another bounce from the buy zone
Receive News & Ratings for Arch Capital Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Capital Group and related companies with MarketBeat.com's FREE daily email newsletter.